DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients.

Karaboyas, Angelo; Xu, Hairong; Morgenstern, Hal; Locatelli, Francesco; Jadoul, Michel; Nitta, Kosaku; Dasgupta, Indranil; Tentori, Francesca; Port, Friedrich K; Robinson, Bruce M.
Kidney Int; 94(3): 589-598, 2018 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-29908836